No Detail Found!

Study on the Effect of Ethanol Ginger Extract on Cell Viability And p53 Level in Breast and Pancreatic Cancer

Author(s)
Soroush Sarami Department of Immunology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran
Maryam Dadmanesh Department of Infectious Diseases, School of Medicine, Aja University of Medical Sciences, Tehran, Iran
Zuhair M. Hassan Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Khodayar Ghorban Department of Immunology, School of Medicine, Aja University of Medical Sciences, Tehran, Iran
Abstract
Cancer is a widespread disease in which regulatory mechanisms of cell growth and proliferation has led into failure and results in continuous cell reproduction. Today, breast and pancreatic cancers are two common and lethal diseases. In recent years anti-cancer effects of natural products like Ginger and its bioactive compounds has taken into consideration. In this study effect of ginger treatment was evaluated on viability and the p53 level of Panc-1 and MCF-7 Cell line. At first Cancerous and normal cells were cultured and then treated with different concentrations of ethanol ginger extract for 24 and 48 hours and eventually MTT assay was conducted to investigate the cytotoxic effect. Then we tested the p53 level in all three cells. In MTT assay we observed that ginger extract kills cancerous cell line in a dose-dependent pattern with IC50 of 40.8 and 61.5 µg/ml for MCF-7 and Panc-1 respectively, while no significant cytotoxic effect was observed on normal cells. P53 level was significantly increased in MCF-7 and Panc-1 and not in PBMCs (P<0/05). A large body of evidence demonstrated that apoptosis is a major active process in cells. Multiple mechanisms are involved in cell growth arrest and apoptosis.as reported P53 plays a key role in ginger-extract-induced apoptosis. Here our study showed ginger induces apoptosis by regulation of p53 in cells bearing mutant and wild-type p53.
Publication Details
Page(s) 115-121
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
P53, Apoptosis, Ginger, Pancreatic cancer, Breast Cancer, MTT
References
Hanahan D.,Weinberg R.A. .2011 .Hallmarks of cancer: the next generation. Cell, 144(5) : 646-74.
Hassan M. .2014 .Apoptosis and molecular targeting therapy in cancer. Biomed Res Int, : 150845.
Thun M.J. .2010 .The global burden of cancer: priorities for prevention. Carcinogenesis, 31(1) : 100-10.
Salehiniya H. .2016 .A Population-based Cancer Registries Study (northern Iran). Caspian J Intern Med, 7(1) : 25-30.
Rojas K.,Stuckey A.,Factors Risk .2016 .Breast Cancer Epidemiology. Clin Obstet Gynecol, 59(4) : 651-672.
Jin X.,Mu P. .2015 .Targeting Breast Cancer Metastasis. Breast Cancer (Auckl), 9(Suppl 1) : 23-34.
Youlden D.R. .2014 .Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med, 11(2) : 101-15.
Miller T.W.,Balko J.M.,Arteaga C.L. .2011 .- kinase and antiestrogen resistance in breast cancer. J Clin Oncol, 29(33) : 4452-61.
Klint A. .2010 .Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006. , 49(5) : 578-607.
Beger H.G. .1999 .Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg, 23(9) : 946-9.
Siegel C.,Desantis C.,Jemal A. .2014 .and. , 64(2) : 104-17.
Ferlay J. .2015 .Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136(5) : E359-86.
Rahib L. .2014 .Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res, 74(11) : 2913-21.
Dorai B.B.,Aggarwal B.B. .2004 .Role of chemopreventive agents in cancer therapy. Cancer Lett, 215(2) : 129-40.
Kaur C.,Agarwal R.,Agarwal R. .2009 .Anticancer and cancer chemopreventive potential of grape seed extract and other grapebased products. J Nutr, 139(9) : 1806S-12S.
Kolonel L.N. .2000 .Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev, 9(8) : 795-804.
Surh Y.J. .2003 .Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer, 3(10) : 768-80.
Srinivasan K. .2014 .Antioxidant potential of spices and their active constituents. Crit Rev Food Sci Nutr, 54(3) : 352-72.
Shukla Y.,Singh M. .2007 .Cancer preventive properties of ginger: a brief review. Food Chem Toxicol, 45(5) : 683-90.
Maghbooli M. .2014 .Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Phytother Res, 28(3) : 412-5.
Mashhadi N.S. .2013 .Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence. Int J Prev Med, 4(Suppl 1) : S36-42.
Raal A. .2013 .Complementary treatment of the common cold and flu with medicinal plants--results from two samples of pharmacy customers in Estonia. PLoS One, 8(3) : e58642.
Al-Nahain A.,Jahan R.,Rahmatullah M. .2014 .Zingiber officinale: A Potential Plant against Rheumatoid Arthritis. , : 159089.
Koo S.W.,M.K. Lim K.W.,Lee K.W. .2015 .Immunomodulatory effects of zingiber officinale in cyclophosphamide-induced immunosuppress mice. Journal of Veterinary Clinics, 32 : 56-61.
Seeram N.P. .2004 .Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem, 52(9) : 2512-7.
Nigam N. .2010 .Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis. Cancer Chemother Pharmacol, 65(4) : 687-96.
Seemann S. .2004 .The tumor suppressor gene TP53: implications for cancer management and therapy. Crit Rev Clin Lab Sci, 41(5- 6) : 551-83.
Willis A.C.,Chen X. .2002 .The promise and obstacle of p53 as a cancer therapeutic agent. Curr Mol Med, 2(4) : 329-45.
Xin Y. .2017 .Recent progress on nanoparticle-based drug delivery systems for cancer therapy. Cancer Biol Med, 14(3) : 228-241.
Elmore S.,Apoptosis : .2007 .a review of programmed cell death. Toxicol Pathol, 35(4) : 495-516.
Bertheau P. .2013 .p53 in breast cancer subtypes and new insights into response to chemotherapy. Breast, 22(Suppl 2) : S27-9.
Yin S.Y. .2013 .Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med, : 302426.
Babasheikhali Rahimi,Rahgozar S.,Mohammadi M. .2019 .Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells. J Cancer Res Clin Oncol, 145(8) : 1987-1998.
Prasad S.,Tyagi A.K. .2015 .Ginger and its constituents: role in prevention and treatment of gastrointestinal cancer. Gastroenterol Res Pract, : 142979.
Karna P. .2012 .Benefits of whole ginger extract in prostate cancer. Br J Nutr, 107(4) : 473-84.
Pashaei-Asl R. .2017 .. The Inhibitory Effect of Ginger Extract on Ovarian Cancer Cell Line; Application of Systems Biology. Adv Pharm Bull, 7(2) : 241-249.
Hessien M. .2012 .Growth inhibition of human non-small lung cancer cells h460 by green tea and ginger polyphenols. Anticancer Agents Med Chem, 12(4) : 383-90.
Sreedhar A.,Li J.,Zhao Y. .2018 .Next-Gen Therapeutics for Skin Cancer: Nutraceuticals. , 70(5) : 697-709.
Nelson ,M.B. Kastan .1994 .DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol, 14(3) : 1815-23.
Zhang S. .2012 .Zerumbone, a Southeast Asian Ginger Sesquiterpene, Induced Apoptosis of Pancreatic Carcinoma Cells through p53 Signaling Pathway. Evid Based Complement Alternat Med, : 936030.
Nalbantsoy A. .2008 .Antimicrobial and Cytotoxic Activities of Zingiber officinalis Extracts. Journal of Pharmacy and Pharmaceutical Sciences, 33 : 78-85.
Park Y.J. .2006 .-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med, 47(5) : 688-97.
El-Ashmawy N.E. .2018 .Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms. Eur J Nutr, 57(3) : 981-989.
Hostanska K. .2004 .Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res Treat, 84(2) : 151-60.
Habib S.H. .2008 .Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics (Sao Paulo), 63(6) : 807-13.
Levine M.E. .2008 .Protein and ginger for the treatment of chemotherapy-induced delayed nausea. J Altern Complement Med, 14(5) : 545-51.
Citronberg J. .2013 .Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila), 6(4) : 271-81.
Sung B. .2008 .Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Cancer Res, 68(21) : 8938-44.
Elbendary A.A. .1996 .Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res, 2(9) : 1571-5.
Elkady A.I. .2012 .Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale. J Biomed Biotechnol, : 614356.
Gaus K. .2009 .Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagAHelicobacter pylori. Pharm Biol, 47(1) : 92-98.
Oyagbemi A.A.,Saba A.B.,O.I. Azeez A.B. . .- gingerol: Its potential roles in cancer chemoprevention. , : .
0

Citations

0

Downloads

12

Views